Synthon BV is an international pharmaceutical company and a leader in the generics field, renowned for its fully integrated capabilities in research and development as well as manufacturing for both active pharmaceutical ingredients (API) and finished products. With a strong expertise in research and development, intellectual property, and regulatory affairs, Synthon’s products have earned approval in approximately 100 countries worldwide, supported by strategic partnerships that facilitate their market reach.

Services include:
– Biologics
– Finished Dosage Forms
– Active Pharmaceutical Ingredients
– Research and Development
– Regulatory Affairs
– Intellectual Property Management

Synthon BV is committed to delivering high-quality pharmaceutical solutions tailored to the needs of its partners and customers, ensuring their place as a reliable supplier within the industry. For more information, please visit synthon.com.